Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial.
Hidaka H, Kokubu S, Sato T, Katsushima S, Izumi N, Igura T, Asahara S, Notsumata K, Osaki Y, Tsuji K, Kawanaka H, Akahoshi T, Hirota S, Matsutani S; NPB-06 study group.
Hidaka H, et al. Among authors: notsumata k.
Hepatol Res. 2018 Feb;48(3):E107-E116. doi: 10.1111/hepr.12934. Epub 2017 Aug 7.
Hepatol Res. 2018.
PMID: 28666312